Tutogen Medical (TTG) Up On Cramer's Comments
TTG Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 7 | New: 23
Tutogen Medical (AMEX: TTG) up on Cramer's comments. He said although the stock is only $1 away from its 52-week high, it looks like Tutogen may move up on a potential deal with other companies. He thinks the company could be bought by Zimmer Holdings (NYSE: ZMH).
Tutogen Medical designs, develops, processes, manufactures and markets sterile biological implant products made from human (allograft) and animal (xenograft) tissue.
Tutogen Medical designs, develops, processes, manufactures and markets sterile biological implant products made from human (allograft) and animal (xenograft) tissue.
You May Also Be Interested In
- Cree (CREE) is Another Dead Man Walking - Analyst
- Nomura Securities Sees Trends Continuing To Be Difficult at Wet Seal, Inc. (WTSLA); Cutting FY12/13 Estimates
- Needham & Company Reiterates a 'Buy' on NetApp (NTAP); Solid 4Q Overshadowed by Conservative 1Q
Create E-mail Alert Related Categories
Analyst Comments, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
